DRUG INDUSTRY CONSENSUS MOVING TOWARD OMITTING MEDICARE DRUG BENEFIT; PhRMA "CANNOT SUPPORT" MEDICARE DRUG BENEFITS REPORTED OUT BY HOUSE COMMITTEES
Executive Summary
A pharmaceutical industry consensus on drugs for the elderly is emerging in support of the omission of a Medicare prescription drug benefit from health reform legislation this year.